News
The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, ...
Canada-based PharmaTher has received US Food and Drug Administration (FDA) approval for its ketamine therapy for surgical ...
1d
MedPage Today on MSNHeart Med Recalled; More Doctors Struggle Financially; Tennis Star's Diagnosis
The ketamine product Ketarx received FDA approval for its indicated uses in surgical pain management, PharmaTher said. The ...
Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased ...
Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, ...
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...
After fifteen years of redefining the all-inclusive experience, Blue Diamond Resorts is taking the next step in its evolution. Beginning August ...
Real-time index price for TSX Venture Composite Index (JX), along with buy or sell indicators, analysis, charts, historical ...
Surfshark, a leading VPN (Virtual Private Network) provider, introduces FastTrack, an innovative technology that optimizes users' traffic paths for improved speed and performance. Built on Nexus ...
2d
TipRanks on MSNPharmaTher’s KETARx™ Gains FDA Approval, Paving Way for Expansion
PharmaTher Holdings Ltd ( ($TSE:PHRM) ) just unveiled an update. PharmaTher Holdings Ltd. has received FDA approval for its ketamine product, ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company ...
CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results